Phase 1/2 Clinical Trial Evaluating 4D-310 in Adults with Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 12–33 Months of Follow-up
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-02-09 09:44:412024-02-09 09:44:41Phase 1/2 Clinical Trial Evaluating 4D-310 in Adults with Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 12–33 Months of Follow-up